Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow

被引：36

作者：

Elstrom, RL

Tsai, DE

Vergilio, JA

Downs, LH

Alavi, A

Schuster, SJ

机构：

[1] Univ Penn, Med Ctr, Dept Med, Philadelphia, PA USA

[2] Univ Penn, Med Ctr, Dept Nucl Med, Philadelphia, PA USA

[3] Univ Penn, Med Ctr, Dept Pathol & Lab Med, Philadelphia, PA USA

来源：

CLINICAL LYMPHOMA | 2004年 / 5卷 / 01期

关键词：

bone marrow biopsy; clinical staging; cytokines; positron emission tomography;

D O I：

10.3816/CLM.2004.n.012

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[F-18]Fluorodeoxyglucose (FDG) positron emission tomography (PET) is increasingly used for the clinical staging of lymphomas and for assessment of response to therapy. We report the case of a woman with classic Hodgkin's lymphoma who had marked FDG uptake by tumor and bone marrow suggestive of diffuse marrow involvement by lymphoma. However, iliac crest bone marrow examination showed marked myeloid hyperplasia without evidence of lymphoma involvement. We discuss the implications for interpretation of FDG-PET imaging of bone marrow in lymphomas.

引用

收藏

页码：62 / 64

页数：3

相关论文

共 15 条

[1]

Buchmann I, 2001, CANCER, V91, P889

[2]

Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].

Carr, R ;

Barrington, SF ;

Madan, B ;

O'Doherty, MJ ;

Saunders, CAB ;

van der Walt, J ;

Timothy, AR .

BLOOD, 1998, 91 (09) :3340-3346

[3]

Utility of FDG-PET scanning in lymphoma by WHO classification [J].

Elstrom, R ;

Guan, L ;

Baker, G ;

Nakhoda, K ;

Vergilio, JA ;

Zhuang, H ;

Pitsilos, S ;

Bagg, A ;

Downs, L ;

Mehrotra, A ;

Kim, S ;

Alavi, A ;

Schuster, SJ .

BLOOD, 2003, 101 (10) :3875-3876

[4]

Positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose (F18-FDG) does not visualize extranodal B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT)-type [J].

Hoffmann, M ;

Kletter, K ;

Diemling, M ;

Becherer, A ;

Pfeffel, F ;

Petkov, V ;

Chott, A ;

Raderer, M .

ANNALS OF ONCOLOGY, 1999, 10 (10) :1185-1189

[5]

Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma [J].

Jerusalem, G ;

Warland, V ;

Najjar, F ;

Paulus, P ;

Fassotte, MF ;

Fillet, G ;

Rigo, P .

NUCLEAR MEDICINE COMMUNICATIONS, 1999, 20 (01) :13-20

[6]

Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL) [J].

Jerusalem, G ;

Beguin, Y ;

Najjar, F ;

Hustinx, R ;

Fassotte, MF ;

Rigo, P ;

Fillet, G .

ANNALS OF ONCOLOGY, 2001, 12 (06) :825-830

[7]

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells [J].

Kapp, U ;

Yeh, WC ;

Patterson, B ;

Elia, AJ ;

Kägi, D ;

Ho, A ;

Hessel, A ;

Tipsword, M ;

Williams, A ;

Mirtsos, C ;

Itie, A ;

Moyle, M ;

Mak, TW .

JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1939-1945

[8]

INCREASED GLUCOSE-METABOLISM IN UNTREATED NON-HODGKINS-LYMPHOMA - A STUDY WITH POSITRON EMISSION TOMOGRAPHY AND FLUORINE-18-FLUORODEOXYGLUCOSE [J].

LAPELA, M ;

LESKINEN, S ;

MINN, HRI ;

LINDHOLM, P ;

KLEMI, PJ ;

SODERSTROM, KO ;

BERGMAN, J ;

HAAPARANTA, M ;

RUOTSALAINEN, U ;

SOLIN, O ;

JOENSUU, H .

BLOOD, 1995, 86 (09) :3522-3527

[9]

LESKINENKALLIO S, 1991, J NUCL MED, V32, P1211

[10]

Lymphoma: Role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging [J].

Moog, F ;

Bangerter, M ;

Diederichs, CG ;

Guhlmann, A ;

Kotzerke, J ;

Merkle, E ;

Kolokythas, O ;

Herrmann, F ;

Reske, SN .

RADIOLOGY, 1997, 203 (03) :795-800